SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-004199
Filing Date
2024-01-17
Accepted
2024-01-17 17:01:52
Documents
13
Period of Report
2023-11-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea191466-8ka1_abvcbio.htm   iXBRL 8-K/A 33472
2 FORM OF AMENDMENT ea191466ex10-2_abvcbio.htm EX-10.2 16298
  Complete submission text file 0001213900-24-004199.txt   229790

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE abvc-20231120.xsd EX-101.SCH 3021
4 XBRL LABEL FILE abvc-20231120_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE abvc-20231120_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT ea191466-8ka1_abvcbio_htm.xml XML 3330
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40700 | Film No.: 24539187
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)